Brightstar Resources (BTR:AU) has announced RIU Conference Presentation
Download the PDF here.
This post appeared first on investingnews.com
This post appeared first on investingnews.com
This post appeared first on investingnews.com
Riverside Resources Inc. (TSXV: RRI) (OTCQB: RVSDF) (FSE: 5YY) (‘Riverside’ or the ‘Company’), is pleased to announce that further to its press release dated September 6, 2024, Riverside’s wholly-owned subsidiary, RRM Exploracion, S.A.P.I. DE C.V. (the ‘Vendor’) has entered into a definitive option agreement (the ‘Option Agreement’) with Questcorp Mining Inc. (‘Questcorp’) dated May 5, 2025, for the 2,520.2 hectare La Union carbonate replacement gold- polymetallic project (the ‘Project’ or ‘La Union’) located in Sonora, Mexico (the ‘Transaction’).
‘We are thrilled to finalize this agreement for the La Union Project, which is a strong asset in Riverside’s portfolio. Securing up to C$5,500,000 in exploration funding from Questcorp is an excellent step forward in advancing this larger Carbonate Replacement Deposit (‘CRD‘) project,’ said John-Mark Staude, CEO of Riverside Resources. ‘Riverside is pleased to have the updated NI 43-101 Technical Report completed and we see an active exploration program launching in the coming weeks with Riverside as the Operator of the exploration program. Riverside is expected to become a shareholder of Questcorp with an initial 9.9% equity interest, subject to final approval by the Canadian Securities Exchange or confirmation that such approval is not required. The first-year work program of C$1,000,000 in exploration expenditures will launch the first round of exploration at the project.’
The La Union Project
The Project is summarized on the Riverside website and is a project that Riverside acquired and further consolidated additional inlier mineral claims. The Project initially identified from Riverside’s work in the western Sonora gold belt through work with AngloGold Ashanti Limited, Centerra Gold Inc., and Hochshild Mining Plc, among others as partners and funding relationships for gold exploration. Initial work by members of the Riverside team, drawing on more than two decades of geological compilation and analysis, identified this region as highly prospective. At the Project, historical mining by the Penoles Mining Company focused on chimney and manto replacement bodies within the upper oxide zones. As a result, the underlying sulfide zones present immediate drill targets for further exploration.
Riverside has spent the past five years consolidating this highly prospective land package, which totals over 22 square kilometers. The Project features favorable limestone host rocks, an extensive alteration footprint, and multiple small-scale historical workings, providing more than eight drill-ready target areas. Key immediate targets include the central Union Mine and the nearby Famosa Mine. With drive-up access, private ranch surface rights, and strong geologic similarities to other major CRDs in Arizona and eastern Mexico, La Union is well positioned for near-term exploration success targeting both oxide and deeper sulfide mineralization.
The Option Agreement
In accordance with the terms of the Transaction, Questcorp can acquire a one-hundred percent (100%) interest in the Project in consideration for completion of a series of cash payments totaling $100,000 CAD, making staged issuances of common shares of Questcorp totaling 19.9%, and incurring $5,500,000 CAD of exploration expenditures on the Project as outlined immediately below:
| Deadline | Cash Payment | Share Issuance | Exploration Expenditures |
| Within two (2) business days of the date of the Option Agreement | $25,000 | N/A | N/A |
| On the Effective Date(1) | N/A | 9.9%(2) | N/A |
| On or before the first anniversary of the Effective Date | N/A | 14.9%(2)(3) | $1,000,000 |
| On or before the second anniversary of the Effective Date | $25,000 | 19.9%(2)(3) | $1,250,000 |
| On or before the third anniversary of the Effective Date | $25,000 | 19.9%(2)(3) | $1,500,000 |
| On or before the fourth anniversary of the Effective Date | $25,000 | 19.9%(2)(3) | $1,750,000 |
| Total | $100,000 | 19.9%(2)(3) | $5,500,000 |
Notes:
|
|||
During the term of the Option Agreement, Riverside, through the Vendor, will remain the program operator for the Project using its local team based in Hermosillo, Sonora. Following exercise of the option under the Option Agreement, Questcorp will grant Riverside a two-and-one half percent (2.5%) net smelter return royalty on commercial production from the Project.
Figure 1. Geologic map with the tenure of the Union internal concession shown in pink. Manto and chimney type CRD targets are shown as red polygons. Riverside now controls all mineral tenures on this map.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6101/250896_df59d6431499eba6_002full.jpg
Figure 2. Cross section looking west with proposed drill sites and drillhole traces. Assays from Riverside’s sampling of rock dump materials from the two mine areas are labeled in black. Red areas are interpreted as manto and chimney target bodies that are now well defined and drill ready. Assays shown on figures 1 and 2 have been previously released and disclosed as summarized below the geochemical QA/QC.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6101/250896_df59d6431499eba6_003full.jpg
Qualified Person & QA/QC:
The scientific and technical data contained in this news release pertaining to the Project was reviewed and approved by Freeman Smith, P.Geo, VP Exploration, a non-independent qualified person to Riverside Resources Inc., who is responsible for ensuring that the information provided in this news release is accurate and who acts as a ‘qualified person’ under National Instrument 43-101 Standards of Disclosure for Mineral Projects.
Rock samples from previous exploration programs discussed above at the Project were taken to the Bureau Veritas Laboratories in Hermosillo, Mexico for fire assaying for gold. The rejects remained with Bureau Veritas in Mexico while the pulps were transported to Bureau Veritas laboratory in Vancouver, BC, Canada for 45 element ICP/ES-MS analysis using 4-acid digestion methods. A QA/QC program was implemented as part of the sampling procedures for the exploration program. Standards were randomly inserted into the sample stream prior to being sent to the laboratory.
About Riverside Resources Inc.:
Riverside is a well-funded exploration company driven by value generation and discovery. The Company has over $4M in cash, no debt and less than 75M shares outstanding with a strong portfolio of gold-silver and copper assets and royalties in North America. Riverside has extensive experience and knowledge operating in Mexico and Canada and leverages its large database to generate a portfolio of prospective mineral properties. Riverside has properties available for option, with information available on the Company’s website at www.rivres.com.
ON BEHALF OF Riverside Resources Inc.
‘John-Mark Staude’
Dr. John-Mark Staude, President & CEO
For additional information contact:
| John-Mark Staude President, CEO Riverside Resources Inc. info@rivres.com Phone: (778) 327-6671 Fax: (778) 327-6675 Web: www.rivres.com |
Eric Negraeff Corporate Communications Riverside Resources Inc. Eric@rivres.com Phone: (778) 327-6671 TF: (877) RIV-RES1 Web: www.rivres.com |
Certain statements in this press release may be considered forward-looking information. These statements can be identified by the use of forward-looking terminology (e.g., ‘expect’,’ estimates’, ‘intends’, ‘anticipates’, ‘believes’, ‘plans’). Such information involves known and unknown risks — including the risk that the Transaction will not be completed as contemplates, or at all, availability of funds, the results of financing and exploration activities, the interpretation of exploration results and other geological data, or unanticipated costs and expenses and other risks identified by Riverside in its public securities filings that may cause actual events to differ materially from current expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250896
News Provided by Newsfile via QuoteMedia
This post appeared first on investingnews.com
Footwear giant Skechers has agreed to be acquired by private equity firm 3G Capital for $63 per share, ending its nearly three-decade run as a public company, the retailer announced Monday.
The price 3G Capital agreed to pay represents a 30% premium to Skechers’ current valuation on the public markets, which is in line with similar takeover deals. Shares of Skechers soared more than 25% after the transaction was announced.
“With a proven track-record, Skechers is entering its next chapter in partnership with the global investment firm 3G Capital,” Skechers’ CEO, Robert Greenberg, said in a news release.
“Given their remarkable history of facilitating the success of some of the most iconic global consumer businesses, we believe this partnership will support our talented team as they execute their expertise to meet the needs of our consumers and customers while enabling the Company’s long-term growth,” he said.
The transaction comes at a difficult time for the retail industry and in particular, the footwear sector, which relies on discretionary spending and overseas supply chains that are now in the crosshairs of President Donald Trump’s trade war.
Last week Skechers signed onto a letter penned by the Footwear Distributors and Retailers of America trade group asking for an exemption from Trump’s tariffs.
And, a little over a week ago, Skechers withdrew its full-year 2025 guidance “due to macroeconomic uncertainty stemming from global trade policies” as companies brace for a drop in consumer spending that will disproportionately impact the footwear and apparel sectors.
Skechers declined to say how much of its supply chain is based in China, which is currently facing 145% tariffs, but cautioned that two-thirds of its business is outside of the U.S. and therefore won’t see as much of an impact.
A source close to the deal who spoke on the condition of anonymity to discuss nonpublic details said the trade environment didn’t force Skechers into a deal and that 3G Capital had been interested in acquiring the company for years.
Tariffs do present some uncertainty in the short term, but 3G Capital believes the long-term outlook of Skechers’ business remains attractive and is well positioned for growth, the person said.
Skechers is the third-largest footwear company in the world behind Nike and Adidas.
Greenberg will stay on as Skechers’ CEO and continue enacting the company’s strategy after the acquisition is completed.
This post appeared first on NBC NEWS
U.S. pharmacy chain Rite Aid on Monday filed for bankruptcy protection for the second time in as many years, according to a court filing.
Pharmacy chains, such as Rite Aid, Walgreens and CVS, have been under pressure as falling drug margins and competition from Walmart and Amazon have led to a closure of hundreds of stores.
Walgreens, facing significant losses, recently agreed to a $10 billion buyout by private equity firm Sycamore Partners — a dramatic decline from its $100 billion valuation a decade ago, underscoring the severe challenges facing traditional pharmacy retailers.
Rite Aid used its previous bankruptcy in 2023 to cut $2 billion in debt, close hundreds of stores, sell its pharmacy benefit company, Elixir, and negotiate settlements with its lenders, drug distribution partner McKesson and other creditors.
The previous bankruptcy also resolved hundreds of lawsuits alleging that Rite Aid ignored red flags when filling suspicious prescriptions for addictive opioid pain drugs.
But despite those settlements, Rite Aid still had $2.5 billion in debt when it emerged from bankruptcy as a private company owned by its lenders in 2024.
According to Monday’s court filing, the company has estimated assets and liabilities in the range of $1 billion to $10 billion.
The company was unable to secure additional capital from lenders, which it needed to continue operating the business, Bloomberg News reported earlier in the day, citing an internal letter from CEO Matthew Schroeder to the company’s employees.
The letter also states that the drug store chain intends to reduce its workforce at its corporate offices in Pennsylvania.
Rite Aid operated about 2,000 pharmacies in 2023 but now has only 1,250 stores across the U.S., with recent closures significantly reducing its presence in markets such as Ohio and Michigan.
This post appeared first on NBC NEWS
A lawyer who represented a government whistleblower in a case that led to President Donald Trump’s first impeachment sued the Trump administration on Monday for ‘unconstitutional retaliation’ after his security clearance was revoked.
Lawyer Mark Zaid argued that the administration’s decision to pull his clearance in March was in retaliation for representing former Department of Homeland Security intelligence chief Brian Murphy, who was key to Trump’s 2019 impeachment.
Murphy filed a whistleblower complaint in 2019 alleging Trump, amid his re-election campaign, pressured Ukrainian President Volodymyr Zelenskiy to investigate then-U.S. presidential candidate Joe Biden and his son Hunter’s business dealings in Ukraine.
The U.S. House of Representatives voted later that year to impeach Trump for abusing the power of his office and obstructing Congress, but he was later acquitted by the Senate.
Zaid’s lawsuit, filed in federal court in Washington, D.C., claims the decision to rescind his security clearance represents a ‘dangerous, unconstitutional retaliation by the President of the United States against his perceived political enemies’ that ‘eschews any semblance of due process.’
The complaint accuses the Trump administration of violating the Administrative Procedures Act, the First Amendment and parts of the Fifth Amendment.
‘No American should lose their livelihood, or be blocked as a lawyer from representing clients, because a president carries a grudge toward them or who they represent,’ Zaid said in a statement. ‘This isn’t just about me. It’s about using security clearances as political weapons.’
The lawsuit cites a 2019 incident in which Trump called Zaid a ‘sleazeball’ at a Louisiana rally and told reporters that the lawyer was a ‘disgrace’ who ‘should be sued.’
The move to pull Zaid’s clearance was ‘a bald-faced attack on a sacred constitutional guarantee: the right to petition the court or federal agencies on behalf of clients,’ the lawsuit says, noting that an ‘attack on this right is especially insidious because it jeopardizes Mr. Zaid’s ability to pursue and represent the rights of others without fear of retribution.’
Trump has also revoked clearances of several other political foes, including former President Joe Biden, former Vice President Kamala Harris, former Secretary of State Hillary Clinton and his own former national security advisor John Bolton, as well as attorneys at other law firms.
Zaid urged the court to rule that Trump’s revocation decision was unconstitutional and reinstate his clearance. He has had access to classified information since 1995 and a security clearance since 2002.
Fox News Digital has reached out to the White House for comment.
Reuters contributed to this report.
This post appeared first on FOX NEWS
President Donald Trump unveiled a budget blueprint last week that includes roughly $6 billion in federal funding cuts to the National Aeronautics and Space Administration (NASA).
Despite the multibillion-dollar slash, a senior official at the space agency told Fox New Digital that the reduction in funding is actually beneficial for efficiency and exploration.
‘The reductions in the President’s blueprint budget counterintuitively represent an opportunity to truly innovate in how we conduct our space missions,’ senior NASA official Ryan Whitley told Fox News Digital in an exclusive statement.
‘Now is the time to reduce the bureaucracy at NASA and turn our attention to the execution of bold new human missions to the Moon and Mars.’
The proposed plan would cut roughly 24% of NASA’s entire budget, and could phase out some major projects like the Artemis moon program. Artemis, which was conceptualized by Trump in his first term, was designed to push the U.S. to return to moon exploration and came after President Barack Obama canceled the Constellation program in 2011.
The original timeline of the Artemis program included a mission to land astronauts on the moon by 2024 via the Space Launch System (SLS) rocket, but technical challenges have delayed the undertaking several years, and it is now set for at least September 2026 should the program survive the cuts.
While funding reduction threatens some existing programs, the White House touted new investments that would bolster the agency in an effort to beat Chinese space innovations.
‘By allocating over $7 billion for lunar exploration and introducing $1 billion in new investments for Mars-focused programs, it ensures that America’s human space exploration efforts remain unparalleled, innovative, and efficient,’ the White House topline preview reads. ‘To achieve these objectives, the Budget would streamline the NASA workforce, IT services, NASA Center operations, facility maintenance, and construction and environmental compliance activities.’
Aligning with the Trump administration’s movement to improve government efficiency, the White House clarified that the budget ‘refocuses [NASA] funding on beating China back to the Moon and on putting the first human on Mars.’
With a heavy reduction in federal funding, it is most likely that outside contractors and companies like Jeff Bezos’ Blue Origin and Elon Musk’s SpaceX will most likely play a bigger role in launching rockets and exploring space.
SpaceX has conducted 479 launches thus far, and Blue Origin has conducted 31.
As the current head of the Department of Government Efficiency (DOGE), though he has announced his intention of leaving the agency to focus more on Tesla and his other ventures, Musk clarified he had no involvement in NASA budget discussions in a post on X last month.
The budget blueprint and the funding changes to NASA still have to make their way through the legislative process, but the U.S. space agency has stood fast in its position that the current proposal will bolster innovation and exploration.
‘We have accomplished the impossible time and time again, but even the best organizations need to take a hard look in the mirror,’ Whitley told Fox News Digital.
‘For the past 25 years, NASA has had access to billions of dollars to advance human exploration beyond Low Earth Orbit. Despite that, in all that time, the United States has only successfully conducted one—uncrewed—test flight around the Moon,’ he said. ‘We know we are capable of accomplishing much more.’
Preston Mizell is a writer with Fox News Digital covering breaking news. Story tips can be sent to Preston.Mizell@fox.com and on X @MizellPreston
This post appeared first on FOX NEWS
A new study exposing a significant number of ‘serious adverse events’ occurring among women who have taken mifepristone, also known as the ‘abortion pill,’ has sparked an outcry from the pro-life community, including experts who spoke to Fox News Digital about what the study means for women in the United States.
‘The biggest thing that will shock most readers of this report is just how different the findings in this study are from what the FDA claims on the abortion drug label,’ Katie Glenn Daniel, SBA Pro Life America director of legal affairs, told Fox News Digital about the recently released study.
‘What they found is that more than one in ten women will go to the emergency room seeking follow-up care after taking the abortion drugs. The FDA claims that’s more like one in 20 women, which is still concerning, right? If you’ve got a one in twenty chance of something happening, you might take that seriously, but one in 10. It is shocking,’ she continued. ‘This means hundreds of thousands of American women have gone to the hospital for complications from abortions through these abortion drugs and the FDA was not collecting information about those situations. So this study shines a light on what has been happening, what ER doctors certainly know is happening. But what our public health institutions have turned a blind eye to.’
Mifepristone is a ‘pregnancy blocker’ that is used in combination with another medication, misoprostol, to terminate pregnancies, according to Mayo Clinic. It is also used to manage early miscarriages, as it helps prepare the body to empty the uterus.
Research by the Ethics & Public Policy Center in Washington, D.C., has revealed that the rate of serious side effects is 22 times higher than what is indicated on the FDA-approved drug label.
After going through an abortion assisted by mifepristone, nearly 11% of women — more than one in 10 — reported experiencing ‘infection, hemorrhaging, or another serious or life-threatening adverse event,’ according to the study summary.
‘These reports, which analyzed the largest known data set of real-world mifepristone use, confirm what physicians like me and our members are seeing in our clinical practice: that abortion drugs pose significant dangers to women,’ Dr. Christina Francis, a board-certified OB/GYN, told Fox News Digital.
‘I have had patients face life-threatening hemorrhage, infection, and more after taking these drugs, which are now available to order online without an in-person physician visit to confirm the age of the pregnancy and rule out risk factors. The fact that these data show a serious complication rate that is 22 times higher than what the FDA states reveals the urgent need for further investigation into complications of drug-induced abortions and for policymakers and agencies to reprioritize women’s safety over the interests of the abortion industry. Women and their children deserve better care than these dangerous drugs.’
Mifepristone, which the Biden administration took steps to ensure was made available to women through the mail, is the most well-known abortion pill in the United States, and approximately 63% of all abortions in the U.S. in 2023 were medication abortions, according to the Guttmacher Institute.
This was an increase from 53% in 2020.
We knew that the Biden administration’s changes to the abortion drug prescribing, which included allowing these drugs to be sent through to mail. We knew that that was harmful for women and girls because there is no medical oversight,’ Daniel told Fox News Digital. ‘You don’t even know if a pregnant woman’s getting these drugs. There have been cases where men order these drugs, to slip them to somebody. The state of Louisiana has a case right now where a mother ordered them and forced her daughter to take them, even though the pregnancy was wanted. So you really lose a lot of the safeguards that are in place when somebody actually physically goes to a doctor’s office.’
Daniel told Fox News Digital she hopes this report will encourage the Trump administration’s FDA to take action to ensure that women and unborn children are protected.
A drug that puts one in ten women in the hospital is certainly not a drug that is quote unquote good for women or caring for women and I think we need to be realistic about that,’ Daniel said.
Daniel also explained that the true harm from the pill is likely even worse than the study only includes certain years and only women who used insurance.
‘So there are tons of women, including those who are the most vulnerable, who are left out of this data,’ Daniel pointed out.
‘There is a lot more to look out here,’ Daniel continued. ‘We see this as the starting point of what the FDA, the CDC, our public health institutions, and our physicians need to be looking at. And we need to have an honest conversation about the fact that 20 years of data shows that these drugs are deadly for children, but they’re also very dangerous for in girls.’
Fox News Digital’s Melissa Rudy contributed to this report
This post appeared first on FOX NEWS
Friedrich Merz, the conservative leader who was poised to become Germany’s next chancellor, failed to win enough votes to secure the country’s top position.
This leaves German Chancellor Olaf Scholz in power even though he had already delivered a farewell address. Merz’s loss marks a historic moment, as it is the first of its kind in post-war Germany.
The result came as a major upset, as Merz was widely expected to win, thanks to a coalition deal involving his party, the Christian Democratic Union (CDU); its Bavarian sister party, the Christian Social Union (CSU); and the Social Democratic Party (SPD).
In February, Merz led his party to a federal election victory and later signed the deal that many assumed would secure him the votes needed to become chancellor. However, on Tuesday, Merz received 310 votes—falling short by six—as at least 18 Members of the German Parliament in the coalition did not back him, according to Reuters.
To secure the position of chancellor, Merz would have needed to win 316 out of 630 in the Bundestag. The coalition of CSU/CDU and SPD has 328 seats, more than enough to secure a majority victory. However, Merz received 310 votes, while 307 members voted against him and nine others abstained.
Despite his unexpected loss, Merz is not out of luck. The Bundestag now has 14 days to elect the next chancellor, and Merz still has a chance of winning the position. Germany’s socialist Left Party, however, is pushing to hold another round of chancellor elections as soon as Wednesday, according to Germany-based news outlet DW.
Merz had already lined up victory trips to France and Poland on Wednesday, Reuters reported, though it is unclear whether he will proceed with the visits as planned following the defeat.
This post appeared first on FOX NEWS